Mohammad Reza Moghaddasnejad: Platelet Activation as a Key Driver of Breast Cancer Progression
Mohammad Reza Moghaddasnejad, Hematology and Oncology Researcher, shared a post on LinkedIn:
“Breast cancer cells alter platelet biology.
Breast cancer cells influence platelet biology through multiple mechanisms.
These cells secrete interleukin-6 (IL-6), which stimulates the liver to increase the production of thrombopoietin (TPO).
Elevated levels of TPO promote megakaryocyte maturation in the bone marrow, leading to an increased number of circulating platelets in patients.
In addition, tumor cells release various soluble factors and exosomes that act on peripheral blood platelets, altering their transcriptome and proteome.
These alterations generate a platelet phenotype that actively contributes to the progression of breast cancer.
Moreover, breast cancer cells participate in platelet activation by directly interacting with platelets and secreting tissue factor (TF), which induces thrombin generation and facilitates the platelet activation process.
In their direct interaction with platelets, breast cancer cells express surface ligands such as podoplanin, mucin, CD44, and CD97, which bind to their respective receptors on platelets—including CLEC-2, CD62P, and integrin αIIbβ3—and play key roles in triggering platelet activation.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 13:0810 Posts Not to Miss This Week
-
Oct 18, 2026, 12:58Pierpaolo Di Micco: DOACs vs Vitamin K Antagonists in Long-Term Anticoagulation
-
Oct 18, 2026, 12:51Arianne Missimer: Understanding Ferritin Levels Beyond the Normal Range
-
Oct 18, 2026, 12:37Roberto C. Iglesias: Colon Cancer Prevention Beyond Supplements and Vitamins
-
Oct 18, 2026, 12:27Rafael Alejandro Camero Del Vecchio: Paroxysmal Nocturnal Hemoglobinuria Advancing Complement Inhibition with Ravulizumab
-
Oct 18, 2026, 12:26Abdul Mannan: When INR Misleads – Rethinking Bleeding Risk in Cirrhosis
-
Oct 18, 2026, 12:14Stéphane Laurent: The People and Technology Behind Safe Blood Transfusion
-
Oct 18, 2026, 12:14Abhi Kapuria: When VTE Prophylaxis Breaks Down in the ICU
-
Oct 18, 2026, 11:37Lee Anne Sorto: Beyond Compliance – Making Audits Count in Transfusion Safety